njshtsy - 优莎纳在中国获得生产厂房
-
我的日志
[@more@]优莎纳在中国获得生产厂房
QQ:717337320 电话：１３８１５４０５７５８优莎纳在中国获得生产厂房Usana 公司与盐湖城发布消息：公司已经在中国大陆购买了可供生产护肤品用品的厂房，不过购买的具体条文和价目尚未公布 。
“这一举措说明 usana 公司进驻中国市场的决心和该公司所实施的具体步骤” Usana 公司总裁Dave Wentz说， “最近中国政府所公布的直销管理条例是对在中国合法从事直销企业的一个很好的指引，我们会根据指引中的内容积极做出相应的准备，并且筹划进入这个全球最具潜力的市场 ”
“直销管理条例”将于本年度12月1日正式实施，然而 usana 公司获得产品销售的许可以及获得合法牌照的时间尚未能确定，这可能需要长达12个月的时间
附：原文
USANA Acquires Manufacturing Facility in ChinaSALT LAKE CITY--(BUSINESS WIRE)--Sept. 20, 2005--USANA Health Sciences Inc. (NASDAQ: USNA) today announced that it has purchased for cash a personal care manufacturing facility in China. The experienced local management team will remain in place and the facility features expansion capability. The terms of the transaction were not disclosed.
"This marks a significant first step for our long-term plan of developing the Chinese market," said USANA President Dave Wentz. "The recent release of the new regulations that will govern direct selling in China allows us to actively prepare for entry into one of the world's largest direct selling markets."
The regulations indicate that the new direct selling laws will go into effect on Dec. 1, 2005. USANA's timeline for receiving a direct selling license and obtaining product approvals is uncertain, but could take as long as 12 months.
About USANA
USANA develops and manufactures high-quality nutritionals, personal care, and weight management products that are sold directly to preferred customers and associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent associates, the governmental regulation of our products, manufacturing and marketing risks, and uncertainties associated with our planned international expansion, including our potential expansion into China. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.
Riley Timmer, 801-954-7100 (Investor Relations)
investor.relations@us.usana.com
SOURCE: USANA Health Sciences Inc.阅读全文(39) | 回复(0) | 引用通告(0)
评论（共0条评论）